Atara Biotherapeutics – (NASDAQ:ATRA)

Atara Biotherapeutics (NASDAQ:ATRA) Receives a Downgrade In a recent research report distributed to Clients on Tuesday, 15 December, Citigroup cut shares of Atara Biotherapeutics (NASDAQ:ATRA)…

Atara Biotherapeutics (NASDAQ:ATRA) Receives a Downgrade In a note made public earlier today, Citigroup cut shares of Atara Biotherapeutics (NASDAQ:ATRA) to a “Sell” rating from…

Atara Biotherapeutics (NASDAQ:ATRA) Rating Reaffirmed They currently have a $40.00 PT on Atara Biotherapeutics (NASDAQ:ATRA). The target price by JMP Securities would suggest a potential…

Atara Biotherapeutics (NASDAQ:ATRA) Receives a Downgrade Atara Biotherapeutics (NASDAQ:ATRA) was cut by research professionals at Citigroup from their past Buy rating to a Sell rating…